Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging - Top-Institutions - MDSpire

Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging

  • By

  • Julia Madlaina Kunz

  • Peter Maloca

  • Andreas Allemann

  • David Fasler

  • Savas Soysal

  • Silvio Däster

  • Marko Kraljević

  • Gulbahar Syeda

  • Benjamin Weixler

  • Christian Nebiker

  • Vincent Ochs

  • Raoul Droeser

  • Harriet Louise Walker

  • Martin Bolli

  • Beat Müller

  • Philippe Cattin

  • Sebastian Manuel Staubli

  • January 22, 2024

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Surgical Oncology
    • Radiology
    • Pancreatic Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Radiology
    • Cancer Imaging

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Radiology
    • Surgical Oncology

  • #4

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Surgical Oncology
    • Radiology
    • Medical Imaging Technology

  • #5

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Radiology
    • Surgical Oncology
    • Biomedical Engineering

Original Source(s)

Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging

  • by Julia Madlaina Kunz, Peter Maloca, Andreas Allemann, David Fasler, Savas Soysal, Silvio Däster, Marko Kraljević, Gulbahar Syeda, Benjamin Weixler, Christian Nebiker, Vincent Ochs, Raoul Droeser, Harriet Louise Walker, Martin Bolli, Beat Müller, Philippe Cattin, Sebastian Manuel Staubli

  • January 22, 2024

Related Content

Transumbilical laparoscopic-assisted appendectomy: a feasible minimally invasive option for pediatric acute appendicitis with comparable outcomes to three-port laparoscopic appendectomy

Early Enteral Feeding Tied to Fewer Complications

Benefit driven by fewer infections and pulmonary events, though overall complication rates were similar

FDA Grants Accelerated Approval for OTOF Gene Therapy

A one-time intracochlear gene therapy improved hearing outcomes in patients with OTOF-related sensorineural hearing loss in the phase 1/2 CHORD trial.